Study on the Effects of Riociguat in Patients with Early Pulmonary Vascular Disease
- Substances:Riociguat
France- Participants:18–64 years · 65+ years
- Substances:Riociguat
Rare diseases
Investigational molecules
Locations
FranceStudy on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
FranceStudy of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors
FranceStudy on DF1001, Nivolumab, and Paclitaxel for Patients with Advanced Solid Tumors
FranceStudy on Nivolumab with Drug Combination for Patients with Intermediate Stage Liver Cancer
FranceStudy on [18F]-Fludarabine and Gadoteric Acid for Imaging in Patients with Newly Diagnosed Primary CNS Lymphoma
FranceStudy on Mavorixafor for Treating WHIM Syndrome in Patients
FranceStudy of Ribociclib and Letrozole for Patients with High-Risk Estrogen Receptor-Positive, HER2-Negative Breast Cancer
FranceStudy on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments
FranceStudy on the Effects of Verapamil Hydrochloride for Adults with Type 1 Diabetes to Preserve Beta-Cell Function
FranceStudy of Ivosidenib or Enasidenib with Chemotherapy for Patients with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with IDH1 or IDH2 Mutation
FranceStudy of nitrous oxide and medical air inhalation in elderly patients with treatment-resistant depression
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.